Menu
Back to User profile » Prof. Dr. Matthias Augustin
Papers published by Prof. Dr. Matthias Augustin:
Learning from the Experiences in the COVID-19 Pandemic – Impact on Quality of Life and Challenges for the Staff of a Dermatological Hospital and Rehabilitation Center in Germany: A Retrospective Analysis
Kuhls LJ, Demiri J, Weidlich A, Weidlich S, Trinkaus J, Steinbrink K, Augustin M, Tsianakas A
Clinical, Cosmetic and Investigational Dermatology 2023, 16:3279-3290
Published Date: 13 November 2023
Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment
Augustin M, Sommer R, Blome C, Kirsten N, Langenbruch A
Patient Preference and Adherence 2023, 17:1335-1345
Published Date: 1 June 2023
Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy
Langenbruch A, Wüstenberg E, Wolf H, Augustin M
Journal of Asthma and Allergy 2022, 15:611-621
Published Date: 11 May 2022
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
Hampton P, Borg E, Hansen JB, Augustin M
Psoriasis: Targets and Therapy 2021, 11:123-131
Published Date: 3 November 2021
Population-Based Epidemiologic Study in Venous Diseases in Germany – Prevalence, Comorbidity, and Medical Needs in a Cohort of 19,104 Workers
Kirsten N, Mohr N, Gensel F, Alhumam A, Bruning G, Augustin M
Vascular Health and Risk Management 2021, 17:679-687
Published Date: 29 October 2021
Prevalence and Cutaneous Comorbidity of Acne Vulgaris in the Working Population
Kirsten N, Mohr N, Augustin M
Clinical, Cosmetic and Investigational Dermatology 2021, 14:1393-1400
Published Date: 2 October 2021
Prevalence and Associated Diseases of Seborrheic Skin in Adults
Kirsten N, Mohr N, Alhumam A, Augustin M
Clinical Epidemiology 2021, 13:845-851
Published Date: 18 September 2021
Prevalence and Medications of Atopic Dermatitis in Germany: Claims Data Analysis
Hagenström K, Sauer K, Mohr N, Dettmann M, Glaeske G, Petersen J, Garbe C, Steimle T, Augustin M
Clinical Epidemiology 2021, 13:593-602
Published Date: 22 July 2021
Determining the Minimal Important Difference for the Wound-QoL Questionnaire
Topp J, Blome C, Augustin M, Mohr N, Debus ES, Diener H, Sommer R
Patient Preference and Adherence 2021, 15:1571-1578
Published Date: 14 July 2021
Epidemiology of Vitiligo – A Dual Population-Based Approach
Mohr N, Petersen J, Kirsten N, Augustin M
Clinical Epidemiology 2021, 13:373-382
Published Date: 26 May 2021
Documenting Patient Data in Psoriasis Clinical Practice—Patient Focus Groups Supporting Psoriasis Experts’ Decision-making
Otten M, Augustin M
Patient Preference and Adherence 2021, 15:549-557
Published Date: 8 March 2021
Measuring the importance of health domains in psoriasis – discrete choice experiment versus rating scales
Gutknecht M, Schaarschmidt ML, Danner M, Blome C, Augustin M
Patient Preference and Adherence 2018, 12:363-373
Published Date: 15 March 2018
Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study
Augustin M, Goepel L, Jacobi A, Bosse B, Mueller S, Hopp M
Clinical, Cosmetic and Investigational Dermatology 2017, 10:373-384
Published Date: 22 September 2017